Boaz Mendzelevski
24  Ergebnisse:
Personensuche X
?
2

Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/..:

Mendzelevski, Boaz ; Ferber, Georg ; Janku, Filip...
Cancer Chemotherapy and Pharmacology.  81 (2018)  6 - p. 1129-1141 , 2018
 
?
3

Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate..:

Tran, Jonathan Q. ; Hartung, Jeffrey P. ; Olson, Allan D....
Clinical Pharmacology in Drug Development.  7 (2017)  3 - p. 263-276 , 2017
 
?
5

Clinical Development Approaches and Statistical Methodologi..:

Geiger, Mary Jane ; Mehta, Cyrus ; Turner, J. Rick...
Therapeutic Innovation & Regulatory Science.  49 (2015)  1 - p. 50-64 , 2015
 
?
 
?
9

Cardiac safety of rasagiline, a selective monoamine oxidase..:

Mendzelevski, Boaz ; Sprenger, Craig R. ; Spiegelstein, Ofer.
Int. Journal of Clinical Pharmacology and Therapeutics.  52 (2014)  3 - p. 192-201 , 2014
 
?
11

Assessment of the cardiac safety of prucalopride in healthy..:

Mendzelevski, Boaz ; Ausma, Jannie ; Chanter, Dennis O....
British Journal of Clinical Pharmacology.  73 (2012)  2 - p. 203-209 , 2012
 
?
 
?
13

Management of aortic dissection complicating coronary inter..:

Mendzelevski, Boaz ; Sigwart, Ulrich
Catheterization and Cardiovascular Diagnosis.  43 (1998)  4 - p. 491-491 , 1998
 
?
14

Rupture of coronary artery and cardiac tamponade complicati..:

Mendzelevski, Boaz ; Sigwart, Ulrich
Catheterization and Cardiovascular Diagnosis.  40 (1997)  4 - p. 368-371 , 1997
 
?
15

Treatment of spontaneous coronary artery dissection: Report..:

Klutstein, Marc W. ; Tzivoni, Dan ; Bitran, Dani...
Catheterization and Cardiovascular Diagnosis.  40 (1997)  4 - p. 372-376 , 1997
 
1-15